These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 22055338
1. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von Dadelszen P. Am J Obstet Gynecol; 2012 Feb; 206(2):163.e1-7. PubMed ID: 22055338 [Abstract] [Full Text] [Related]
2. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction. Cetin I, Mazzocco MI, Giardini V, Cardellicchio M, Calabrese S, Algeri P, Martinelli A, Todyrenchuk L, Vergani P. J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483 [Abstract] [Full Text] [Related]
3. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787 [Abstract] [Full Text] [Related]
5. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study. Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304 [Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Malamitsi-Puchner A, Boutsikou T, Economou E, Sarandakou A, Makrakis E, Hassiakos D, Creatsas G. Mediators Inflamm; 2005 Oct 24; 2005(5):293-7. PubMed ID: 16258196 [Abstract] [Full Text] [Related]
14. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. J Clin Endocrinol Metab; 2005 Aug 24; 90(8):4895-903. PubMed ID: 15886253 [Abstract] [Full Text] [Related]
18. Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study. Beharier O, Shusterman E, Szaingurten-Solodkin I, Weintraub AY, Sheiner E, Swissa SS, Gitler D, Hershkovitz R. Arch Gynecol Obstet; 2015 Nov 24; 292(5):1027-32. PubMed ID: 25940355 [Abstract] [Full Text] [Related]
19. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia. Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Gómez-Montes E, Denk B, Galindo A. Ultrasound Obstet Gynecol; 2013 May 24; 41(5):530-7. PubMed ID: 23303638 [Abstract] [Full Text] [Related]
20. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W, Verlohren S. J Perinat Med; 2014 Jan 24; 42(1):61-8. PubMed ID: 23929878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]